Catalogue
≥ 99 % · HPLC
Retatrutide
Triple agonist (GIP/GLP-1/glucagon) – a current research topic.
€119.00
incl. VAT, plus shipping
Size
In stock
1
For research use only. Not intended for use in humans or animals. Not a drug, food or cosmetic.
COA on request
Lab tested
DHL shipping
EU company
COA per batch
Retatrutide targets three receptors simultaneously and is the subject of intensive preclinical research.
Retatrutide is an investigational peptide binding three receptors of the incretin and glucagon system simultaneously.
Multi-receptor pharmacologyEnergy balance models
More in the lexicon